BSFA Analyst Ratings
Moderate Buy
4 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BSFA Stock 12 Month Forecast
Average Price Target
―| Highest Price TargetCHF100.16 | Average Price TargetCHF88.04 | Lowest Price TargetCHF73.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
CHF73.5
Hold
―
Initiated
07/17/26
Guggenheim
CHF100.16
Buy
―
Reiterated
07/14/26
H.C. Wainwright
CHF97.73
Buy
―
Reiterated
07/13/26
Barclays
CHF80.77
Buy
―
Reiterated
05/20/26
Truist Financial
―
Hold
―
Reiterated
05/11/26
Piper Sandler
CHF89.66
Buy
―
Reiterated
04/23/26
Jefferies
CHF96.93
Buy
―
Reiterated
03/25/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
CHF73.5
Hold
―
Initiated
07/17/26
Guggenheim
CHF100.16
Buy
―
Reiterated
07/14/26
H.C. Wainwright
CHF97.73
Buy
―
Reiterated
07/13/26
Barclays
CHF80.77
Buy
―
Reiterated
05/20/26
Truist Financial
―
Hold
―
Reiterated
05/11/26
Piper Sandler
CHF89.66
Buy
―
Reiterated
04/23/26
Jefferies
CHF96.93
Buy
―
Reiterated
03/25/26
Best Analysts Covering ANI Pharmaceuticals
3 Months
Success Rate
7/9 ratings generated profit
Average Return
+15.36%
Copying Faisal Khurshid's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +15.36% per trade.
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+22.21%
Copying Faisal Khurshid's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +22.21% per trade.
2 Years
Success Rate
8/9 ratings generated profit
Average Return
+22.36%
Copying Faisal Khurshid's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +22.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BSFA Analyst Recommendation Trends
Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
5
5
2
2
1
Buy
2
5
4
5
2
Hold
1
2
1
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
12
7
9
4
Each month's total comprises the sum of three months' worth of ratings.
BSFA Financial Forecast
BSFA Stock Forecast FAQ
What is CH:BSFA’s average 12-month price target, according to analysts?
Based on analyst ratings, ANI Pharmaceuticals Inc’s 12-month average price target is 88.04.
What is CH:BSFA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:BSFA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ANI Pharmaceuticals Inc a Buy, Sell or Hold?
ANI Pharmaceuticals Inc has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 2 hold ratings and 0 sell ratings.
What is ANI Pharmaceuticals Inc’s share price target?
The average share price target for ANI Pharmaceuticals Inc is 88.04. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF100.16 ,and the lowest forecast is CHF73.50. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is CHF100.16 ,and the lowest forecast is CHF73.50. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about ANI Pharmaceuticals Inc?
ANI Pharmaceuticals Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of ANI Pharmaceuticals Inc?
To buy shares of CH:BSFA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.